Intercept(Biotechnology) is Drug Discovery in United States that focus on Intercept Pharmaceuticals business. Founded in 2002. They cover business area such as Intercept Pharmaceuticals, novel therapeutic, chronic liver disease, obeticholic acid, oca, an agonist, OCA, Ocaliva, primary biliary cirrhosis, nonalcoholic steatohepatitis, nash.
2002
( 22 years old in 2024 )
Intercept Pharmaceuticals
-
10 Hudson Yards
37th Floor
New York, NY 10001
United States
Private
Intercept Pharmaceuticalsnovel therapeuticchronic liver diseaseobeticholic acidocaan agonistOCAOcalivaprimary biliary cirrhosisnonalcoholic steatohepatitisnash
* We use standard office opening hours in near Intercept(Biotechnology)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Intercept(Biotechnology) is Drug Discovery business from United States that founded in 2002 (22 years old in 2024), Intercept(Biotechnology) business is focusing on Intercept Pharmaceuticals.
Intercept(Biotechnology) headquarter office and corporate office address is located in 10 Hudson Yards 37th Floor New York, NY 10001 United States.
Intercept(Biotechnology) was founded in United States.
In 2024, Intercept(Biotechnology) is currently focus on Intercept Pharmaceuticals sector.
Above is snippet of Google Trends for "Intercept Pharmaceuticals" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Intercept(Biotechnology), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.